Although brachytherapy is an effective treatment modality for gynecological cancer, a significant proportion of patients develop late treatment-related vaginal toxicity, negatively impacting their quality of life and limiting recurrent disease detection by preventing adequate clinical examination during the post-treatment surveillance period. Consistent with the literature, results from a study at Princess Margaret revealed that current vaginal toxicity management education and training may be inadequate. The investigators seek to implement and evaluate a new online brachytherapy discharge education program (BrachDEP) to support patient engagement in self-management.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Patient Satisfaction with access to education (CBI)
Timeframe: 1 year
Patient Satisfaction with access to education (EQ-5D-5L)
Timeframe: 1 year
Patient Satisfaction with access to education (EORTC-QOL)
Timeframe: 1 year
Patient Satisfaction with access to education (SVQ)
Timeframe: 1 year
Patient Satisfaction with access to education (PS-CaTE)
Timeframe: 1 year